New York, May 18 (TIWN) Administering monoclonal antibodies -- a Covid-19 treatment given early after Coronavirus infection -- can reduce the risk of hospitalisation and death by 60 per cent in people most likely to suffer complications of the disease, according to study.

Monoclonal antibodies are a type of medication that seeks out the Covid-19 virus in a person's body and blocks it from infecting their cells and replicating.